Article Details

AstraZeneca's Tezspire approved in the EU for patients with severe asthma - PharmaTimes

Retrieved on: 2022-09-21 10:32:48

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Tezspire approved in the EU for patients with severe asthma - PharmaTimes. View article details on hiswai:

Excerpt

Tezspire is a maintenance therapy for patients with no phenotype or biomarker limitations. AstraZeneca's Tezspire – also known as Tezepelumab ...

Article found on: www.pharmatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up